Joseph Sparano
Joseph Sparano
Professor of Medicine & Women's Health, Albert Einstein College of Medicine, Montefiore Medical
Verified email at - Homepage
Cited by
Cited by
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, ...
Annals of oncology 26 (2), 259-271, 2015
Prospective validation of a 21-gene expression assay in breast cancer
JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ...
New England Journal of Medicine 373 (21), 2005-2014, 2015
Weekly paclitaxel in the adjuvant treatment of breast cancer
JA Sparano, M Wang, S Martino, V Jones, EA Perez, T Saphner, AC Wolff, ...
New England Journal of Medicine 358 (16), 1663-1671, 2008
Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer
JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ...
New England Journal of Medicine 379 (2), 111-121, 2018
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199
S Adams, RJ Gray, S Demaria, L Goldstein, EA Perez, LN Shulman, ...
Journal of clinical oncology 32 (27), 2959, 2014
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system
CA Hudis, WE Barlow, JP Costantino, RJ Gray, KI Pritchard, ...
Journal of Clinical Oncology 25 (15), 2127-2132, 2007
Development of the 21-gene assay and its application in clinical practice and clinical trials
JA Sparano, S Paik
Journal of Clinical Oncology 26 (5), 721-728, 2008
Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of life
AB Moadel, C Shah, J Wylie-Rosett, MS Harris, SR Patel, CB Hall, ...
Journal of Clinical Oncology 25 (28), 4387-4395, 2007
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS …
LD Kaplan, JY Lee, RF Ambinder, JA Sparano, E Cesarman, A Chadburn, ...
Blood 106 (5), 1538-1543, 2005
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast
LJ Solin, R Gray, FL Baehner, SM Butler, LL Hughes, C Yoshizawa, ...
Journal of the National Cancer Institute 105 (10), 701-710, 2013
Prognostic utility of the 21-gene assay in hormone receptor–positive operable breast cancer compared with classical clinicopathologic features
LJ Goldstein, R Gray, S Badve, BH Childs, C Yoshizawa, S Rowley, ...
Journal of Clinical Oncology 26 (25), 4063, 2008
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
B Asselain, W Barlow, J Bartlett, J Bergh, E Bergsten-Nordström, J Bliss, ...
The Lancet Oncology 19 (1), 27-39, 2018
Case fatality rate of cancer patients with COVID-19 in a New York hospital system
V Mehta, S Goel, R Kabarriti, D Cole, M Goldfinger, A Acuna-Villaorduna, ...
Cancer discovery 10 (7), 935-941, 2020
TAILORx: trial assigning individualized options for treatment (Rx)
JA Sparano
Clinical breast cancer 7 (4), 347-350, 2006
Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern …
JA Sparano, P Bernardo, P Stephenson, WJ Gradishar, JN Ingle, S Zucker, ...
Journal of Clinical Oncology 22 (23), 4683-4690, 2004
Urinary estrogen metabolites and breast cancer: a case-control study.
GC Kabat, CJ Chang, JA Sparano, DW Sepkovie, XP Hu, A Khalil, ...
Cancer Epidemiology and Prevention Biomarkers 6 (7), 505-509, 1997
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with …
H Roché, L Yelle, F Cognetti, L Mauriac, C Bunnell, J Sparano, P Kerbrat, ...
Journal of clinical oncology 25 (23), 3415-3420, 2007
Estrogen-and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase …
SS Badve, FL Baehner, RP Gray, BH Childs, T Maddala, ML Liu, ...
Journal of Clinical Oncology 26 (15), 2473-2481, 2008
Assessing tumor infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (6), 311, 2017
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma
JA Sparano, JY Lee, LD Kaplan, AM Levine, JC Ramos, RF Ambinder, ...
Blood 115 (15), 3008-3016, 2010
The system can't perform the operation now. Try again later.
Articles 1–20